@book{52f478d90a7746a6850919c08ba74528,
title = "EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to Pacran{\textregistered} and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006",
abstract = "Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Pacran{\textregistered} and defence against bacterial pathogens in the lower urinary tract. The food that is the subject of the claim is Pacran{\textregistered}. The Panel considers that the food, Pacran{\textregistered}, which is the subject of the claim is sufficiently characterised in relation to the claimed effect. The Panel considers that defence against bacterial pathogens in the lower urinary tract is a beneficial physiological effect. One human study from which conclusions could be drawn for the scientific substantiation of the claim showed no effect of Pacran{\textregistered} on defence against bacterial pathogens in the lower urinary tract. The Panel concludes that a cause and effect relationship has not been established between the consumption of Pacran{\textregistered} and defence against bacterial pathogens in the lower urinary tract.",
keywords = "Pacran {\textregistered}, Proanthocyanidins, Cramberry, Vaccinium macrocarpon, Urinary tract, Health claims",
author = "\{EFSA Publication\} and Inge Tetens",
year = "2014",
doi = "10.2903/j.efsa.2014.3656",
language = "English",
series = "the EFSA Journal",
number = "3656",
publisher = "Europen Food Safety Authority",
address = "Italy",
}
SDG 3 Good Health and Well-being